Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metabolic Imaging: Predicting Histopathologic Response to Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer

NCT00394615 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT00394615
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00394615 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metabolic Imaging: Predicting Histopathologic Response to Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer
Lead sponsor
Stanford University
Phase
Not applicable
Overall status
Terminated
Start date
October 31, 2003
Completion date
October 31, 2005
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rectal cancer